31st Mar 2023

Interim results to 31 December 2022

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...

30th Mar 2023

Genedrive® MT-RNR1 ID Test receives positive final recommendation by NICE

NICE issues final guidance for use in the NHS through Early Value Assessment programme...

20th Mar 2023

Genedrive® MT-RNR1 to commence roll out in Greater Manchester

genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Ge...